Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts

Gilead Sciences (NASDAQ:GILD) has an average 12-month price target of $158.78 from analysts, which is above its current share price of $150.93. The company recently reported better-than-expected quarterly results with adjusted EPS of negative $6.75 and revenue of $7.80 billion, a 10.6% year-over-year increase. Insider activity showed sales of 105,000 shares worth $14.6 million during the last quarter, while institutional investors own 83.67% of the stock.